Kaansariin sombaa seelii xiqqaa hin taane, inni gosa baay'ee baramaa ta'e, sadarkaa hunda waliin walqabatee waggaa shan bara bara bara jiraachuun isaa gara 18% ta'a.
Haa ta'u malee, yoo kaansariin kun dursanii argame, lakkoofsi lubbuu barachuu waggaa shan hanga 57% ga'uu danda'a. Kaansariin sombaa seelii xixiqqoon, kan baay'ee hin argamne, sadarkaa hunda waliin ta'uun lakkoofsa lubbuu barachuu waggaa shan gara 7% qaba.
Malli wal'aansa fi fooyya'iinsi fayyaa fooyya'aa kan jiru si'a ta'u, dhukkubsattoonni baay'een kunuunsa fi to'annaa sirrii ta'een yeroo dheeraa jiraachuu fi jireenya gaarii qabaachuu danda'u.
Martini B: [Lung cancer--epidemiology, prognosis and therapy]. Med Monatsschr Pharm. 2006, 29 (6): 217-21.
Zou T, Liu JY, She L, Yin JY, Li X, Li XP, Zhou HH, Chen J, Liu ZQ: The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Front Pharmacol. 2020, 11 (): 1029.
Li L, Zhou Q, Luo D, Xu Y, Yang H, Zhang S, Li A, Li H, Lv C: [A study on the relationship between lung cancer cell apoptosis and prognosis in patients with human non-small cell lung cancer.]. Zhongguo Fei Ai Za Zhi. 1998, 1 (2): 70-3.
Feng YY, Yang Y, Wang YY, Bai XX, Hai P, Zhao R: [Hypomethylation of DAPL1 associated with prognosis of lung cancer patients with EGFR Del19 mutation]. Zhonghua Zhong Liu Za Zhi. 2021, 43 (12): 1264-1268.
Xiao Y, Zhu S, Yin W, Liu X, Hu Y: IGFBP-4 expression is adversely associated with lung cancer prognosis. Oncol Lett. 2017, 14 (6): 6876-6880.
Lang J, Zhao Q, He Y, Yu X: Bone turnover markers and novel biomarkers in lung cancer bone metastases. Biomarkers. 2018, 23 (6): 518-526.
Ejjennoo: fayyaa
Weebsaayitiin kun kaayyoo barnootaa fi odeeffannoo qofaaf kan qophaa'e yoo ta'u, gorsa fayyaa ykn tajaajila ogummaa kennuu miti.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numerical content. For example, the number of people diagnosed with a specific disease.
Yeroo hunda waa'ee dhukkuba tokkoo gorsa ogeessa fayyaa ykn ogeessa fayyaa ga'eessa ta'e biraa gaafadhu. Gorsa fayyaa ogeessaa hin tuffatin ykn waan weebsaayitii kana irratti dubbisteef isa barbaaduu hin daangeffatin. Yoo rakkoo fayyaa qabaachuu dandeessan yoo ta'e, hatattamaan 911 bilbilaa ykn gara kutaa ariifachiisaa dhihoo deemaa. Weebsaayitii kana ykn itti fayyadama isaatiin hariiroon ogeessa fayyaa fi dhukkubsataa hin uumamu. BioMedLib ykn hojjettoonni isaa, ykn namni weebsaayitii kana irratti gumaache kamiyyuu, odeeffannoo asitti kenname ykn itti fayyadama isaa ilaalchisee ibsa ykn yaada hin kennine hin kennine.
Ejjennoo: Mirga bu'uuraa
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) abbootii seeraa meeshaaleen intarneetii irratti mul'atan mirga isaanii seera abbaa seerummaa Yunaayitid Isteetis jalatti cabsu jedhanii amanuuf furmaata ni kenna.
DMCA'n beeksiinsi keessan waa'ee cabsaa seeraa kan himatamu odeeffannoo armaan gadii akka dabalatu gaafata: (1) ibsa hojii seeraa kan cabsaa seeraa kan himatamu ta'e; (2) ibsa qabiyyee cabsaa seeraa kan himatamu fi odeeffannoo qabiyyee isaa akka argannu nu dandeessisu ga'aa ta'e; (3) odeeffannoo wal qunnamtii keessan, kan akka teessoo keessan, lakkoofsa bilbilaa fi teessoo iimeelii keessan; (4) ibsi keessan qabiyyee akkaataa komatamanitti akka hin hayyamamne amantaa gaarii akka qabdan ibsa;
(5) beeksifannaa keessatti odeeffannoon sirrii akka ta'e fi mirgi abbaa qabeenyaa akka cabse kan himatamu akka ta'e labsii ati mallatteessite;
fi (6) mallattoo qaamaa ykn elektirooniksii abbaa seeraa ykn nama bakka bu'aa abbaa seeraa ta'uun akka hojjetu hayyamame.
Odeeffannoowwan armaan olitti tarreeffaman hunda kan hin dabalne yoo ta'e, dhimmi komii keessan akka hin mari'atamne gochuu danda'a.
Walitti dhufeenyi
Gaaffii / yaada kamirrayyuu qabdan nutti ergi.
What is prognosis of lung cancer?
The prognosis of lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the overall health of the patient.
Non-small cell lung cancer, which is the most common type, has a 5-year survival rate of about 18% for all stages combined.
However, if the cancer is caught early, the 5-year survival rate can be as high as 57%. Small cell lung cancer, which is less common, has a 5-year survival rate of about 7% for all stages combined.
It is important to note that these are general statistics and individual outcomes may vary.
Treatment options and advancements in medicine continue to improve, and many patients can live longer and have a better quality of life with proper care and management.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Waa'ee
BioMedLib gaaffii fi deebii lama uumuuf kompiitaroota tooftaa (machine-learning algorithms) fayyadama.
